These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 29885802)

  • 61. Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus.
    Swayne DE; Lee CW; Spackman E
    Avian Pathol; 2006 Apr; 35(2):141-6. PubMed ID: 16595307
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
    Isakova-Sivak I; Korenkov D; Smolonogina T; Tretiak T; Donina S; Rekstin A; Naykhin A; Shcherbik S; Pearce N; Chen LM; Bousse T; Rudenko L
    Virology; 2017 Jan; 500():209-217. PubMed ID: 27829176
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genomic and phylogenetic characterization of novel, recombinant H5N2 avian influenza virus strains isolated from vaccinated chickens with clinical symptoms in China.
    Xu H; Meng F; Huang D; Sheng X; Wang Y; Zhang W; Chang W; Wang L; Qin Z
    Viruses; 2015 Feb; 7(3):887-98. PubMed ID: 25723387
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Protective immunity against influenza virus challenge by norovirus P particle-M2e and HA2-AtCYN vaccines in chickens.
    Elaish M; Xia M; Ngunjiri JM; Ghorbani A; Jang H; Kc M; Abundo MC; Dhakal S; Gourapura R; Jiang X; Lee CW
    Vaccine; 2019 Oct; 37(43):6454-6462. PubMed ID: 31506195
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets.
    Seo SH; Webster RG
    J Virol; 2001 Mar; 75(6):2516-25. PubMed ID: 11222674
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Distribution of avian influenza H5N1 viral RNA in tissues of AI-vaccinated and unvaccinated contact chickens after experimental infection.
    Hassan MK; Kilany WH; Abdelwhab EM; Arafa AS; Selim A; Samy A; Samir M; Le Brun Y; Jobre Y; Aly MM
    Arch Virol; 2012 May; 157(5):951-9. PubMed ID: 22350650
    [TBL] [Abstract][Full Text] [Related]  

  • 68. T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.
    Li J; Arévalo MT; Chen Y; Chen S; Zeng M
    Int J Infect Dis; 2014 Oct; 27():37-43. PubMed ID: 25172265
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses.
    Lu X; Edwards LE; Desheva JA; Nguyen DC; Rekstin A; Stephenson I; Szretter K; Cox NJ; Rudenko LG; Klimov A; Katz JM
    Vaccine; 2006 Nov; 24(44-46):6588-93. PubMed ID: 17030078
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intranasally administered polyethylenimine adjuvanted influenza M2 ectodomain induces partial protection against H9N2 influenza A virus infection in chickens.
    Hajam IA; Kim J; Lee JH
    Vet Immunol Immunopathol; 2019 Mar; 209():78-83. PubMed ID: 30885310
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An inactivated H5N2 vaccine reduces transmission of highly pathogenic H5N1 avian influenza virus among native chickens.
    Poetri ON; Bouma A; Murtini S; Claassen I; Koch G; Soejoedono RD; Stegeman JA; van Boven M
    Vaccine; 2009 May; 27(21):2864-9. PubMed ID: 19428896
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Improved cellular immune response induced by intranasal boost immunization with chitosan coated DNA vaccine against H9N2 influenza virus challenge.
    Zhang T; Tian Y; Zhang X; Wang W; He Y; Ge C; Jia F; Wang Z; Jiang Y
    Microb Pathog; 2024 Oct; 195():106871. PubMed ID: 39163919
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses.
    Rodriguez L; Nogales A; Murcia PR; Parrish CR; Martínez-Sobrido L
    Vaccine; 2017 Aug; 35(34):4374-4381. PubMed ID: 28709557
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
    Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rapid production of a H₉ N₂ influenza vaccine from MDCK cells for protecting chicken against influenza virus infection.
    Ren Z; Lu Z; Wang L; Huo Z; Cui J; Zheng T; Dai Q; Chen C; Qin M; Chen M; Yang R
    Appl Microbiol Biotechnol; 2015 Apr; 99(7):2999-3013. PubMed ID: 25646963
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of the protective efficacy of a commercial vaccine against different antigenic groups of H9N2 influenza viruses in chickens.
    Sun Y; Pu J; Fan L; Sun H; Wang J; Zhang Y; Liu L; Liu J
    Vet Microbiol; 2012 Apr; 156(1-2):193-9. PubMed ID: 22019289
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype].
    Smolonogina TA; Desheva IuA; Rekstin AR; Mironov AN; Rudenko LG
    Vopr Virusol; 2013; 58(6):31-5. PubMed ID: 24772644
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunoprotection against influenza virus H9N2 by the oral administration of recombinant Lactobacillus plantarumNC8 expressing hemagglutinin in BALB/c mice.
    Shi SH; Yang WT; Yang GL; Cong YL; Huang HB; Wang Q; Cai RP; Ye LP; Hu JT; Zhou JY; Wang CF; Li Y
    Virology; 2014 Sep; 464-465():166-176. PubMed ID: 25083619
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Partial heterologous protection by low pathogenic H9N2 virus against natural H9N2-PB1 gene reassortant highly pathogenic H5N1 virus in chickens.
    Dash SK; Kumar M; Kataria JM; Nagarajan S; Tosh C; Murugkar HV; Kulkarni DD
    Microb Pathog; 2016 Jun; 95():157-165. PubMed ID: 27057675
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development of an effective contemporary trivalent avian influenza vaccine against circulating H5N1, H5N8, and H9N2 in Egypt.
    Gomaa MR; Khalil AA; Kandeil A; Sabir JSM; Kayed A; Moatasim Y; El Saied MF; El-Safty MM; Kayali G; Ali MA
    Poult Sci; 2019 Dec; 98(12):6289-6295. PubMed ID: 31265106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.